Grace V. Milton Gowda, M. Pharm., Ph.D., RAC

Int'l Biomedical Regulatory Sciences and Clinical Trials Programs
Director, International Biomedical Regulatory Sciences Program
Associate Professor, College of Pharmacy

Int'l Biomedical Regulatory Sciences and Clinical Trials Programs

Education

RAPS Executive Education Program, Kellogg Business School, 2016

Regulatory Affairs Certification, USA, 2008

Clinical Post-Doctoral fellow, CNS, 1994

Ph.D. (Pharmacology and Toxicology), The University of Texas at Austin, 1993

Foreign Pharmacy Graduate Equivalency, USA, 1992

Master of Pharmacy (Pharmacology), University of Nagpur, Nagpur, India, 1986

Bachelor of Pharmacy, University of Madras, Madras, India, 1984

More About

Dr. Gowda has more than 25 years of experience in the pharmaceutical industry.  View her complete CV for details.

Areas of Expertise

Dr. Gowdy’s areas of interest include product development; basic research, especially in the field of neuroscience; clinical research in mental health; targeted drug delivery, specifically in immunology; clinical trials; Chemistry Manufacturing and Controls (CMC); registration and maintenance of animal health products; and regulatory policy

Honors, Awards, and Achievements

Chapter Leadership Award, Healthcare Businesswomen Association, 2009

Regulatory Sciences Service Award, AAPS – 2008 and 2009

University First in Master of Pharmacy Degree, Awarded by Nagpur University, India 1987

Rathanagiriswaran Medal for top score in Pharmaceutical Chemistry, Awarded by Indian Pharmaceutical Association, Madras, India, 1984

Affiliations

Healthcare Business Women Association (HBA)

American Association of Pharmaceutical Scientists (AAPS)

Selected Publications
  1. Milton, G. V., Randall, P. K. and Erickson, C. K.: Low-Dose Effect of Ethanol on Locomotor Activity Induced by Activation of the Mesolimbic System. Alc. Clin. Exp. Res. 19:768-776 (1995)
  2. Milton, G. V. and Jann, M. W.: As Needed Administration of Antipsychotic Drugs: Pharmacokinetic Considerations. Clin. Pharmacokin. 28:494-504 (1995)
  3. Gerber, D. A., Oettinger, C. W., D’Souza, M., Milton, G. V., Larsen, C. P. and Pearson, T. C.: Prolongation of Murine Cardiac Allograft Survival by Microencapsulated TNFa and IL-1 Neutralizing Antibodies.  J. of Drug Targeting. 3:311-315 (1995)
  4. Oettinger, C.W., D’Souza, M.J. and Milton, G.V.: In Vitro Comparison of Cytokine Release from ATS and OKT3:  Inhibition with soluble and Microencapsulated Neutralizing antibodies.  Transplantation 62:1690-1693 (1996)
  5. Huang, X.R., Tipping, P.G., Apostolopoulos, J. Oettinger, C., D’Souza, M., Milton, G., Holdsworth, S.R.: Mechanisms of T cell induced glomerular injury in anti-GBM glomerulonephritis in rats. Clin. Exp. Immunol.109:134-142 (1997)
  6. D’Souza, M.J., Oettinger, C.W., Shah, A., Tipping, P.G., Huang, X.R. and Milton, G.V.: Macrophage depletion by albumin microencapsulated (MC) clondronate: Attenuation of cytokine release and glomerulonephritis in rat.  Drug Develop. Ind. Pharm.  25:591-596 (1999)
  7. Oettinger, C.W., D’Souza, M.J. and Milton, G.V.: Targeting macrophages with microspheres containing cytokine neutralizing antibodies prevents lethality in gram negative peritonitis. J. Interferon Cytokine Res. 19:33-40 (1999)
  8. D’Souza, M.J., Oettinger, C.W., and Milton, G.V.: Evaluation of Microspheres Containing Neutralizing Antibodies in Endotoxemia. Drug Develop. Ind. Pharm. 25: 727-734, (1999)
  9. D’Souza, M.J., Oettinger, C.W., Milton, G.V. and Tracey, K.J.: Prevention of Lethality and Suppression of Proinflammatory cytokines in Experimental Septic shock by Microencapsulated CNI-1493. Interferon. Cyt. Res. 19: 1125-1133 (1999)
  10. D’Souza, M.J., Oettinger, C.W., Milton, G.V. and Tracey, K.J.: Microsperes containing Neutralizing Antibodies to Tumor Necrosis Factor- and Interleukin-1 Protect Rats from Staphylococcus aureus-induced Peritonitis. Interferon. Cyt. Res. 20: 907-913 (2000)